The ODP Corporation Announces First Quarter 2024 Results
First Quarter Revenue of $1.9 Billion with GAAP EPS of $0.40; Adjusted EPS of $1.05 GAAP Operating Income of $18 Million; Net Income of $15 Million; Adjusted EBITDA... Read more.
NeueHealth Reports First Quarter 2024 Results
Drove strong Q1 ‘24 results, focused on delivering coordinated, consumer-centric care to all populations through strong provider and payor partnerships and proactive... Read more.
International Seaways Reports First Quarter 2024 Results
NEW YORK–(BUSINESS WIRE)–International Seaways, Inc. (NYSE: INSW) (the “Company,” “Seaways,” or “INSW”), one of the largest tanker companies... Read more.
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield,... Read more.
KBRA Releases Research – FHFA Closed-End Seconds: Effect on PLS?
NEW YORK–(BUSINESS WIRE)–#creditratingagency–The Federal Housing Finance Agency (FHFA) on April 16 issued a notice and a request for comment related... Read more.
Lubrizol Showcases LIPOFER™ Microencapsulation Technology, Introduces New EU Food-Grade Approval for Carbopol® Polymers at Vitafoods Europe 2024
Technologies offer innovative solutions for maximum iron benefits and consumer-centric nutraceuticals, demonstrating Lubrizol’s commitment to improving well-being... Read more.
HF Sinclair Corporation Reports 2024 First Quarter Results and Announces Regular Cash Dividend
Reported net income attributable to HF Sinclair stockholders of $314.7 million, or $1.57 per diluted share, and adjusted net income of $142.3 million, or $0.71 per... Read more.
Eaton to supply innovative ELocker differential system to leading electrified vehicle manufacturer
SOUTHFIELD, Mich.–(BUSINESS WIRE)–#EVtechnologies–Intelligent power management company Eaton today announced it has been selected by a leading... Read more.
Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
The study met its primary endpoint achieving clinically meaningful and statistically significant reductions across all TEV-‘749 dose groups versus placebo in the... Read more.
Cardano Foundation Names Giorgio Zinetti as Chief Technology Officer
ZUG, Switzerland–(BUSINESS WIRE)–The Cardano Foundation, the Swiss-based not-for-profit organization tasked with advancing Cardano as a public digital... Read more.